Institutional Sign In

Go

Amgen Czech Republic - Total Cash From Investing

Amgen CR`s Total Cash From Investing reached -58.4 CZK mil in 2017. This is 572 % less than in the previous year.

$1.99

Buy Total Cash From Investing data for Amgen Czech Republic.

$19.99

Buy all data for Amgen Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ... ...           -52.0 -20.0 -21.0 44.7 -69.9    
Bayer Czech Republic CZK mil ... ... ...             ... ... ... ... ... ... ...    
GlaxoSmithKline Czech Republic CZK mil ... ... ...           ... ... ... ... ... ... ... ...    
Merck Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...    
Novartis Czech Republic CZK mil                       -2.94 -17.3 -19.9 -15.1 -41.3    
Pfizer Czech Republic CZK mil ... ...             ... ... ... ... ... ... ... ...    
Roche Czech Republic CZK mil ... ... ...                 -65.5 -159 -127 -125 -114   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               -9.97 -13.5 -3.03 1.31 -2.71    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... -1.14 -3.08 -5.23 -4.39    
Walmark CZK mil ... ... ...                 -67.0 -39.0 -244 -71.2 -441